Toggle navigation
About
About Us
Management Team
Board of Directors
Advisory Board
Partnering
Technology
rhCollagen
3D Bioprinting
Product Pipeline
Collink.3D Bioinks
Collink.3D 50
Collink.3D 50L
Collink.3D 90
Gut-on-a-Chip
Medical Aesthetics
Dermal Fillers
Breast Implants
Vergenix products
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Media Room
Publications
Posters and Presentations
Media Coverage
Videos
Sustainability
Contact
Contact us
Careers
search
Search for:
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Email Alerts
Company Info
Overview
Presentations
Management Team
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
SEC Filings
Overview
All SEC Filings
Annual Reports
Filing Type:
View All
144
20-F
424B3
424B5
6-K
8-A12B
CERT
CORRESP
CT ORDER
D
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
F-3/A
F-6
POS AM
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Date
Form
Description
PDF
XBRL
Pages
05/22/19
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
05/01/19
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
32
05/01/19
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
EX-99.2
EX-99.3
32
04/24/19
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
04/23/19
CT ORDER
Confidential treatment order
1
04/22/19
424B3
Prospectus filed pursuant to Rule 424(b)(3)
28
04/19/19
EFFECT
Notice of Effectiveness
1
04/18/19
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
04/08/19
F-3/A
Registration statement for specified transactions by certain foreign private issuers
Documents
EX-5.1
EX-23.1
40
04/01/19
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
13
Previous
1…
11
12
13
14
15
16
17
18
19
20
…25
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Details
explore
CollPlant Ltd
4 Oppenheimer Street
P.O. Box 4132
Rehovot 7670104, Israel
LinkedIn
Youtube
Twitter
local_phone
+972 73 2325600
local_printshop
+972 73 2325602
mail
info@collplant.com
® 2024 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20